SCHEMBL25465014

SCHEMBL25465014

CC1O[C@@H](C[C@]23CCC(C)(C)CC2C2=CCC4[C@@]5(C)CCC(=O)C(C)(C)C5CC[C@@]4(C)[C@]2(C)CC3)C(O)C(O)[C@H]1O

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.63
▸ CES1 P23141 2/20 0.63
▸ PTPN1 P18031 12/20 0.61
▸ PTPN2 P17706 6/20 0.61
▸ F3 P13726 1/20 0.61
▸ PNLIP P16233 1/20 0.61
▸ NOS2 P35228 1/20 0.61
▸ NFKB1 P19838 2/20 0.56
▸ NFKB2 Q00653 2/20 0.56
▸ RELA Q04206 2/20 0.56
▸ AKR1B10 O60218 1/20 0.54
▸ AKR1B1 P15121 1/20 0.54
▸ PTPN6 P29350 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25464873 0.92 CES2 (0.63) CES2CES1PTPN1PTPN2F3
SCHEMBL24190829 0.92 CES2 (0.63) CES2CES1PTPN1PTPN2F3
SCHEMBL25465196 0.92 CES2 (0.63) CES2CES1PTPN1PTPN2F3
SCHEMBL24190743 0.90 PTPN1 (0.63) CES2CES1PTPN1PTPN2F3
SCHEMBL24190844 0.88 CES2 (0.64) CES2CES1PTPN1PTPN2F3
3-Oxo-Erythrodiol SCHEMBL18688302 0.83 CES2 (0.76) CES2CES1PTPN1PTPN2F3
SCHEMBL24190927 0.83 PTPN1 (0.43) CES2CES1PTPN1PTPN2F3
SCHEMBL24190938 0.83 PTPN1 (0.43) CES2CES1PTPN1PTPN2F3
SCHEMBL24190841 0.82 CES2 (0.59) CES2CES1PTPN1PTPN2F3
SCHEMBL25466859 0.82 CES2 (0.59) CES2CES1PTPN1PTPN2F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180445-A1 PENTACYCLIC TRITERPENOID GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2023-05-17 — — EP disclosed
Send feedback